Latest Amgen Stories
PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)
MD Anderson's Moon Shots Program key to Collaboration THOUSAND OAKS, Calif. and HOUSTON, Jan.
LAKE FOREST, Ill., Jan.
THOUSAND OAKS, Calif., Jan. 8, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 33(rd) Annual J.P. Morgan Healthcare Conference at 9:30 a.m. PT on Tuesday, Jan.
Alliance Combines Amgen's Oncology Targets and Kite's Leading CAR T Cell Therapy Platform to Develop new Therapeutic Candidates THOUSAND OAKS, Calif.
RnRMarketResearch.com adds “Vectibix (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.
Sponsorship Secures Resources Needed for Biotech Startups to Advance Innovative Research CAMBRIDGE, Mass., Dec.
THOUSAND OAKS, Calif., Dec. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $0.79 per share dividend for the first quarter of 2015.
Believed to be the First Company to Have a Biosimilar Filing Accepted for Review of Amgen's Neulasta® TORONTO, Dec.
First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif. and LONDON, Dec.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.